Featured:
QCovid highly commended for ‘best use of technology in Patient Safety’ at the 2021 HSJ Patient Safety Awards
23 September 2021
COVID-19 Infection, Respiratory and Acute Care QResearch
Professor Julia Hippisley-Cox and her team have been Highly Commended in the ‘Best use of technology in Patient Safety’ category for the QCovid risk calculator at this year’s Health Service Journal Patient Safety Awards.
Vaccinated groups at highest risk of Covid-19 hospitalisation and death identified using new QCovid tool
20 September 2021
COVID-19 Infection, Respiratory and Acute Care QResearch
New algorithm predicts those most at risk of serious Covid-19 outcomes from 14 or more days after second vaccination dose, when substantial immunity is expected to have developed Authors hope this new risk tool will allow those who perceive risk to be high to make more informed decisions regarding shielding and potentially inform policy and clinical decisions on booster vaccine doses and monoclonal antibodies
Can electronic cigarettes help people quit smoking? (Updated)
16 September 2021
Published this week is the fourth update of the Cochrane review of ‘Electronic cigarettes for smoking cessation’, and the second since it switched to a living review format in October 2020. This review brings together the most up to date research findings on the effect and safety of using electronic cigarettes to help people to stop smoking.
MSc EBHC students awarded EBHC Dissertation Prize for outstanding Dissertation
16 September 2021
Awards & appointments Research methods & EBM Students
Congratulations to Michael Tringale, who recently completed the MSc in Evidence-Based Health Care, and Claire Duddy, who recently completed the MSc in EBHC Systematic Reviews, as they are both awarded this year's EBHC Dissertation Prize for outstanding dissertation.
Oxford announces the founding of the new Bennett Institute for Applied Data Science
16 September 2021
Awards & appointments Bennett Institute Infection, Respiratory and Acute Care
The Bennett Institute for Applied Data Science at the University of Oxford has been established to pioneer the better use of data, evidence and digital tools in healthcare and policy, optimizing the impact of interventions to achieve improved outcomes. The Institute has been made possible due to a generous donation from The Peter Bennett Foundation
New collaboration to assess revolutionary multi-cancer blood test in trial, for future use in the NHS
15 September 2021
The Nuffield Department of Primary Care Health Sciences is co-leading on a recently announced nation-wide collaborative project to evaluate a new technology which aims to detect early signs of multiple types of cancer.
Department cancer-risk research featured in special edition of PLOS Medicine focussed on advances in early cancer detection
2 September 2021
Cancer Digital health & innovation Infection, Respiratory and Acute Care
The research, led by researchers at the Nuffield Department of Primary Care Health Sciences, is highlighted in a special collection of studies that focus on early cancer detection, hailed by the Editors as “cutting edge, and potentially scalable, innovations that have the potential to inform research, policy, and clinical cancer management.”
Covid-19, not vaccination, presents biggest blood clot risks
27 August 2021
COVID-19 Infection, Respiratory and Acute Care
Oxford researchers have today announced the results of a blood clot study, suggesting lower risk with vaccine than infection.
COVID-19 population-based study wins journal award
10 August 2021
COVID-19 Infection, Respiratory and Acute Care QResearch
Research into the risk of hospital admission from COVID-19 is recognised with a "Best Research Paper Award" from the journal Heart.
New research to explore family experiences of long COVID
19 July 2021
Awards & appointments COVID-19
The Nuffield Department of Primary Care Health Sciences is delighted to announce that it has been awarded £557,674 to investigate how families are managing to cope with ‘long covid’ and to understand how best they can be supported.
People with learning disabilities “extremely vulnerable” to the effects of COVID-19, finds study
15 July 2021
COVID-19 Infection, Respiratory and Acute Care
The results, from within the OpenSAFELY platform, are based on electronic health records for more than 17 million people registered with a general practice in England linked to hospital admission and mortality data.
COVID-19 risk prediction tool wins national award
15 July 2021
COVID-19 Infection, Respiratory and Acute Care
The QCovid®-powered COVID-19 Population Risk Assessment, developed by a cross-organisational team and rolled across NHS England, has won the Florence Nightingale Award for Excellence in Healthcare Data Analytics.
Benefit-to-harm balance of statins for healthy adults "generally favourable", suggests Oxford-led research
15 July 2021
Cardiovascular & metabolic DPhil
Statins are associated with a small increased risk of side effects in patients without a history of heart disease, but these effects are mild compared with the potential benefits of treatment in preventing major cardiovascular events, finds a study led by Oxford University researchers.
PRINCIPLE trial 'highly commended' for innovative use of health data
5 July 2021
COVID-19 Clinical trials Infection, Respiratory and Acute Care
The PRINCIPLE trial has been highly commended at the Health Data Research UK Awards for the way in which patient data is utilised so participants are contacted about the trial soon after receiving a positive test result.
Long COVID cases appear to be under-reported in NHS GP records, shows OpenSAFELY analysis
30 June 2021
COVID-19 Infection, Respiratory and Acute Care
Good data on Long COVID will be crucial for research into the prevalence of Long COVID, its causes and consequences, and to plan services effectively, say researchers following their analysis of 96% of electronic healthcare records in England using the OpenSAFELY platform.
Ivermectin to be investigated as a possible treatment for COVID-19 in the PRINCIPLE trial
23 June 2021
COVID-19 Clinical trials Infection, Respiratory and Acute Care
From today, ivermectin is being investigated in the UK as part of the Platform Randomised Trial of Treatments in the Community for Epidemic and Pandemic Illnesses (PRINCIPLE), the world’s largest clinical trial of possible COVID-19 treatments for recovery at home and in other non-hospital settings.
Ethnic minority children may be disproportionately impacted by COVID-19, suggests analysis
21 June 2021
COVID-19 DPhil Infection, Respiratory and Acute Care
There are higher proportions of ethnic minority children in England testing positive for COVID-19 than white children, with Asian children more likely to be admitted to hospital with the illness, finds an observational analysis of 2.6 million healthcare records led by Oxford University researchers.
Celebrating International Clinical Trials Day 2021
20 May 2021
Each year, International Clinical Trials Day recognises the people who conduct clinical trials, giving our community a chance to say thank you for everything they do to improve public health. This year our trials unit staff are sharing what makes them proud to be part of Oxford’s Primary Care Clinical Trials Unit.
Blog: Opinions from our research and teaching
Contact our communications team
Opinions expressed are those of the authors and not of Oxford University. Readers' comments will be moderated - see our guidelines for further information.